Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy.
about
Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an exampleOlder breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.Treatment priorities in oncology: do we want to live longer or better?Shared decision-making in question.The role of chemotherapy at the end of life: "when is enough, enough?".Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.Assessing patients' needs and preferences in the management of advanced colorectal cancer.Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials.Listen to their answers! Response behaviour in the measurement of physical and role functioning.Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.Methodological assessment of HCC literatureEliciting patients' preferences for adjuvant chemotherapy in breast cancer: development and validation of a bedside decision-making instrument in a French Regional Cancer Centre.Intraoperative radiotherapy for early breast cancer: do health professionals choose convenience or risk?Decisions for lung cancer chemotherapy: the influence of physician and patient factors.Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.Assessment of benefits and risks in development of targeted therapies for cancer--The view of regulatory authorities.Pharmacotherapy for treatment of lung cancer in the elderly.Half-sandwich ruthenium(II) biotin conjugates as biological vectors to cancer cells.Evaluation of the chemotherapy patient monitor: an interactive tool for facilitating communication between patients and oncologists during the cancer consultation.Systemic adjuvant therapy of breast cancer.Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment.The early discontinuation of palliative chemotherapy in older patients with cancer.Patient preferences for oropharyngeal cancer treatment de-escalation.The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer "fighting against cancer".Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.Cancer beliefs in cancer survivors, cancer relatives and persons with no cancer experience.How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma
P2860
Q28069620-EDCF9F17-B48D-41CA-A8DF-1A6B5B33A80DQ33627703-76420A67-3EA4-45BC-9E2F-FE9B8B8B8BC3Q34031335-7DBC7450-FA31-4609-A751-2582EDFFAB18Q34194591-72D0EDC1-0953-4DFE-AC64-04BAD7ABB041Q34997049-AC7AF105-51B9-438E-9F8D-0D04035BF0C9Q36036034-FB33C6B2-9617-49D2-9059-9D89C34FEE38Q36291291-2207B598-9E70-4D2C-A0EF-24F217FCE7C5Q36291299-AC701F2F-8837-49BB-803F-CAB7420729F0Q36606761-7CC07F27-DA86-424B-A161-0EE570B6AB59Q36612331-277BB12E-6608-4A46-8B3D-BEFD2E290474Q36914381-D706CD99-8226-4E89-99A9-604C6A5C36E1Q36963820-4DC77B18-7EF5-4A5C-83FD-0E1FEEF27354Q37367790-99969F96-65E2-405B-83A9-0EB993263FC6Q37533221-BAA9754C-F735-410F-8341-5C146411C444Q37879997-E7C173EE-6BF0-4884-96B9-ACC3884A0567Q38103514-9684C658-A060-4A2B-BF6F-5365716D259CQ38284222-992C59CF-AABA-4E0D-B7B7-7AA452ADD352Q38386745-88577858-CEC4-43E9-8B48-3B6B3D87DD3CQ38910350-13C33E88-C7C1-4F39-ABAB-7DEFB7181EC9Q40662186-CA5AF1A1-2BD5-45B3-92F3-914AA19D9A18Q41360912-E2163934-0CE7-426E-BC86-B140C145C0B4Q43481926-6A73B03E-ED6F-43FA-A00E-761F2163C2B6Q43902443-DD7E94B3-B177-4632-B4AC-DE7F85A7DCBFQ45378293-94F4B207-24C3-46DE-8918-D1C7C98C429DQ47592040-99E06F8A-B808-4109-8C58-5A36E54AC5A1Q48706070-9A5F93C9-EB35-4552-B3FA-746A3BBC6CE3Q53580262-8B25DC66-0F58-4635-BA92-BFCA290E01B6Q57816342-09A8FEF2-E59F-440D-AF28-8CB350FB9340
P2860
Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cancer patients, doctors and n ...... undertake cancer chemotherapy.
@en
Cancer patients, doctors and n ...... undertake cancer chemotherapy.
@nl
type
label
Cancer patients, doctors and n ...... undertake cancer chemotherapy.
@en
Cancer patients, doctors and n ...... undertake cancer chemotherapy.
@nl
prefLabel
Cancer patients, doctors and n ...... undertake cancer chemotherapy.
@en
Cancer patients, doctors and n ...... undertake cancer chemotherapy.
@nl
P2093
P1476
Cancer patients, doctors and n ...... undertake cancer chemotherapy.
@en
P2093
P304
P356
10.1016/0959-8049(95)00513-7
P577
1995-11-01T00:00:00Z